These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunological studies in psoriasis. The quantitative evaluation of cell-mediated immunity in patients with psoriasis by experimental sensitization to 2,4-dinitrochlorobenzene. Obalek S; Haftek M; Sliński W Dermatologica; 1977; 155(1):13-25. PubMed ID: 303184 [TBL] [Abstract][Full Text] [Related]
3. Restoration of normal experimental DNCB hypersensitivity development in symptom-free patients with psoriasis. Gliński W; Obałek S; Haftek M Arch Dermatol Res; 1978 Sep; 263(1):115-9. PubMed ID: 718260 [No Abstract] [Full Text] [Related]
4. Restoration of normal experimental DNCB hypersensitivity development in symptom-free patients with psoriasis. Gliński W; Obałek S; Haftek M Arch Dermatol Res; 1978; 263(1):115-9. PubMed ID: 757454 [No Abstract] [Full Text] [Related]
5. Delayed-type allergy in patients with ulcerative colitis. 1. Contact allergy to 2,4-dinitrochlorobenzene. Tomecki R Mater Med Pol; 1975; 7(2):93-8. PubMed ID: 1142826 [No Abstract] [Full Text] [Related]
6. Skin sensitization to 2, 4 dinitrochlorobenzene (DNCB) in the first months of life. Cassimos C; Kanakoudi-Tsakalidis F; Spyroglou K; Ladianos M; Tzaphi R J Clin Lab Immunol; 1980 Mar; 3(2):111-3. PubMed ID: 7205930 [TBL] [Abstract][Full Text] [Related]
7. [Course of experimental mycosis against a background of sensitization to 2,4-dinitrochlorobenzene (DNCB)]. Kostiuk EP; Bannikov EA Vestn Dermatol Venerol; 1979 Jan; (1):57-60. PubMed ID: 419880 [No Abstract] [Full Text] [Related]
8. Induction of contact sensitivity to DNCB with in vitro dinitrophenylated lymph node cells. Nakagawa S; Aoshima T; Mimura S; Gotoh M; Ueki H Dermatologica; 1980; 161(1):8-11. PubMed ID: 7398979 [TBL] [Abstract][Full Text] [Related]
9. Antigen-binding T and B lymphocytes in sensitization and unresponsiveness to dinitrochlorobenzene (DNCB) contact sensitivity. Polak L; Rydén A; Roelants GE Immunology; 1975 Mar; 28(3):479-84. PubMed ID: 1079198 [TBL] [Abstract][Full Text] [Related]
10. Quantitation of sensitization and responsiveness to dinitrochlorobenzene in normal subjects. Friedmann PS; Moss C; Shuster S; Simpson JM Br J Dermatol; 1983 Jul; 109 Suppl 25():86-8. PubMed ID: 6860585 [TBL] [Abstract][Full Text] [Related]
15. Diminished contact sensitivity response in vitiliginous skin. Uehara M; Miyauchi H; Tanaka S Arch Dermatol; 1984 Feb; 120(2):195-8. PubMed ID: 6696471 [TBL] [Abstract][Full Text] [Related]
16. Lack of cross-reaction between DNCB and chloramphenicol. Strick RA Contact Dermatitis; 1983 Nov; 9(6):484-7. PubMed ID: 6653106 [TBL] [Abstract][Full Text] [Related]
17. Effect of levamisole on skin reactions to DNCB in chronically dialyzed patients. Modai D; Sagi DB; Maor J Nephron; 1980; 25(6):280-2. PubMed ID: 7393370 [TBL] [Abstract][Full Text] [Related]
18. The mechanism of tolerance in contact hypersensitivity to dinitrochlorobenzene in guinea-pigs. Halliday WJ; Walters BA Clin Exp Immunol; 1974 Feb; 16(2):203-12. PubMed ID: 4469216 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic implications of cellular immune defects in operable cancer patients revealed by dinitrochlorobenzene skin contact sensitivity. Ketcham AS; Chretien PB Panminerva Med; 1975; 17(5-6):174-8. PubMed ID: 1057759 [No Abstract] [Full Text] [Related]
20. [Immunological characteristics of the parallergic reactions developing in a combination of experimental mycosis and dermatitis due to dinitrochlorobenzene]. Bannikov EA; Bakhtilin VIa; Gerasimova NM; Kardakova TA Vestn Dermatol Venerol; 1981 Jan; (1):53-7. PubMed ID: 7210871 [No Abstract] [Full Text] [Related] [Next] [New Search]